Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of persistent preformed and de novo donor-specific antibodies detected at 1 year after kidney transplantation on long-term graft survival in Japan: a retrospective study.
Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Kanda S, Narita S, Mitobe Y, Habuchi T. Fujiyama N, et al. Among authors: saito m, saito t. Clin Exp Nephrol. 2019 Dec;23(12):1398-1406. doi: 10.1007/s10157-019-01780-z. Epub 2019 Sep 6. Clin Exp Nephrol. 2019. PMID: 31493185
Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantation.
Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Nara T, Kanda S, Narita S, Kagaya H, Miura M, Habuchi T. Fujiyama N, et al. Among authors: saito m, saito t. Int Immunopharmacol. 2019 Nov;76:105881. doi: 10.1016/j.intimp.2019.105881. Epub 2019 Sep 11. Int Immunopharmacol. 2019. PMID: 31520989
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.
Narita S, Terada N, Nomura K, Sakamoto S, Hatakeyama S, Kato T, Matsui Y, Inokuchi J, Yokomizo A, Tabata KI, Shiota M, Kimura T, Kojima T, Inoue T, Mizowaki T, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H, Habuchi T; Japanese Urological Oncology Group. Narita S, et al. Int J Urol. 2022 Oct;29(10):1147-1154. doi: 10.1111/iju.14938. Epub 2022 May 25. Int J Urol. 2022. PMID: 35613936
Health Utility of Pain Response Versus Nonresponse to Palliative Radiation Therapy for Symptomatic Bone Metastases: Analyses Based on Real-World Data from 26 Centers.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamazaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Asakawa I, Shigematsu N. Saito T, et al. J Palliat Med. 2024 Dec 27. doi: 10.1089/jpm.2024.0208. Online ahead of print. J Palliat Med. 2024. PMID: 39729365
In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds.
Watamura N, Foiani MS, Bez S, Bourdenx M, Santambrogio A, Frodsham C, Camporesi E, Brinkmalm G, Zetterberg H, Patel S, Kamano N, Takahashi M, Rueda-Carrasco J, Katsouri L, Fowler S, Turkes E, Hashimoto S, Sasaguri H, Saito T, Islam AS, Benner S, Endo T, Kobayashi K, Ishida C, Vendruscolo M, Yamada M, Duff KE, Saido TC. Watamura N, et al. Among authors: saito t. Nat Neurosci. 2024 Dec 24. doi: 10.1038/s41593-024-01829-7. Online ahead of print. Nat Neurosci. 2024. PMID: 39719507
12,082 results
You have reached the last available page of results. Please see the User Guide for more information.